The FDA and Stem Cell Therapy

Last week on NPR's All Things Considered, the topic was stem cells and how the FDA (U.S. Food and Drug Administration) is forcing some labs and clinics to close. Some companies are conducting their research in the United States but moving their clinics out of the country to keep them open. It was a very interesting segment, and gives some insight into why people are willing to pay a lot of money and go to these clinics for therapies that aren't fully tested or approved in the United States. You can listen to the segment, or read the transcript, on the NPR website: FDA Challenges Stem Cell Companies As Patients Run Out Of Time.